n-3 PUFA Tx After AMI Linked to Drop in Death, Recurrent AMI
Treatment linked to reduction in all-cause mortality, recurrent acute MI though 12-month follow-up
Tysabri Impacts Seroconversion in John Cunningham Virus
Over 14.8 months, natalizumab treatment linked to 15.9 percent increase of value in JCV+ patients
Carbamazepine Affects Warfarin Anticoagulation
Carbamazepine co-treatment linked to subtherapeutic anticoagulative effect of warfarin
FDA Approves Halaven for Advanced Liposarcoma
FDA says it's first liposarcoma drug to improve survival
Review: Dabigatran Comparable to Warfarin for Nonvalvular A-Fib
Linked to lower risk of intracranial bleeding, but higher risk of gastrointestinal bleeding
Drug Shortages Affecting Emergency Med Up 2008 to 2014
Increases seen in drugs used as direct lifesaving intervention or for high acuity conditions
Prenatal Vitamin D Supplements Don’t Reduce Asthma
No evidence of beneficial effect on asthma, chronic wheezing in two studies
No Beneficial Effects Seen for Cyclosporine A in Reperfused MI
Does not improve ST-segment resolution, hs-cTnT, clinical outcomes, or LV remodeling
Vitamin D Treatment Has No Effect in Prediabetes
Eight weeks of high-dose treatment has no impact on β-cell function, insulin sensitivity, glycemic control
Belatacept Regimen Ups Kidney Transplant Survival
Higher patient, graft survival and mean eGFR with more- and less-intensive belatacept vs. cyclosporine
